X·CON 2019 – Healthtech →
Vice president, chief strategy and operating officer of the Texas Medical Center
Software Engineer at Skelmir
Co-Founder and CEO, DNAnexus
CEO and Fund Manager, Renaissance Venture Capital Fund
Serial Entrepreneur and Investor
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Professor of Systems Biology, Columbia University
October 22, 2019 · Boston
October 29, 2019 · San Francisco
October 31, 2019 · San Diego
There are plenty of smart executives in the world, but they often make poor leaders. That’s because it takes both intelligence and maturity to excel at leadership. And when I say... Read more »
In any business, projects fail, but in biopharmaceuticals, the consequences of failure are especially damaging. Projects in the industry tend to be long and expensive—from clinical trials to regulatory approvals to... Read more »
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Xconomy Insight · Webinar
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Tax credits help tech innovators attract capital, fuel growth
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.